Literature DB >> 17124493

Huntingtin inhibits caspase-3 activation.

Yu Zhang1, Blair R Leavitt, Jeremy M van Raamsdonk, Ioannis Dragatsis, Dan Goldowitz, Marcy E MacDonald, Michael R Hayden, Robert M Friedlander.   

Abstract

Huntington's disease results from a mutation in the HD gene encoding for the protein huntingtin. The function of huntingtin, although beginning to be elucidated, remains largely unclear. To probe the prosurvival function of huntingtin, we modulate levels of wild-type huntingtin in a number of cellular and in vivo models. Huntingtin depletion resulted in caspase-3 activation, and overexpression of huntingtin resulted in caspase-3 inhibition. Additionally, we demonstrate that huntingtin physically interacts with active caspase-3. Interestingly, mutant huntingtin binds active caspase-3 with a lower affinity and lower inhibitory effect on active caspase-3 than does wild-type huntingtin. Although reduction of huntingtin levels resulted in caspase-3 activation in all conditions examined, the cellular response was cell-type specific. Depletion of huntingtin resulted in either overt cell death, or in increased vulnerability to cell death. These data demonstrate that huntingtin inhibits caspase-3 activity, suggesting a mechanism whereby caspase-mediated huntingtin depletion results in a detrimental amplification cascade leading to further caspase-3 activation, resulting in cell dysfunction and cell death.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17124493      PMCID: PMC1698892          DOI: 10.1038/sj.emboj.7601445

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  36 in total

1.  The huntingtin interacting protein HIP1 is a clathrin and alpha-adaptin-binding protein involved in receptor-mediated endocytosis.

Authors:  S Waelter; E Scherzinger; R Hasenbank; E Nordhoff; R Lurz; H Goehler; C Gauss; K Sathasivam; G P Bates; H Lehrach; E E Wanker
Journal:  Hum Mol Genet       Date:  2001-08-15       Impact factor: 6.150

Review 2.  Apoptosis and caspases in neurodegenerative diseases.

Authors:  Robert M Friedlander
Journal:  N Engl J Med       Date:  2003-04-03       Impact factor: 91.245

3.  Maintenance of caspase-3 proenzyme dormancy by an intrinsic "safety catch" regulatory tripeptide.

Authors:  S Roy; C I Bayly; Y Gareau; V M Houtzager; S Kargman; S L Keen; K Rowland; I M Seiden; N A Thornberry; D W Nicholson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

4.  Neurons lacking huntingtin differentially colonize brain and survive in chimeric mice.

Authors:  A Reiner; N Del Mar; C A Meade; H Yang; I Dragatsis; S Zeitlin; D Goldowitz
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

5.  Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease.

Authors:  M Chen; V O Ona; M Li; R J Ferrante; K B Fink; S Zhu; J Bian; L Guo; L A Farrell; S M Hersch; W Hobbs; J P Vonsattel; J H Cha; R M Friedlander
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

6.  Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice.

Authors:  I Dragatsis; M S Levine; S Zeitlin
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

7.  Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease.

Authors:  Cheryl L Wellington; Lisa M Ellerby; Claire-Anne Gutekunst; Danny Rogers; Simon Warby; Rona K Graham; Odell Loubser; Jeremy van Raamsdonk; Roshni Singaraja; Yu-Zhou Yang; Juliette Gafni; Dale Bredesen; Steven M Hersch; Blair R Leavitt; Sophie Roy; Donald W Nicholson; Michael R Hayden
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

8.  Huntingtin's neuroprotective activity occurs via inhibition of procaspase-9 processing.

Authors:  D Rigamonti; S Sipione; D Goffredo; C Zuccato; E Fossale; E Cattaneo
Journal:  J Biol Chem       Date:  2001-03-05       Impact factor: 5.157

9.  Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.

Authors:  C Zuccato; A Ciammola; D Rigamonti; B R Leavitt; D Goffredo; L Conti; M E MacDonald; R M Friedlander; V Silani; M R Hayden; T Timmusk; S Sipione; E Cattaneo
Journal:  Science       Date:  2001-06-14       Impact factor: 47.728

10.  Depletion of wild-type huntingtin in mouse models of neurologic diseases.

Authors:  Yu Zhang; Mingwei Li; Martin Drozda; Minghua Chen; Shengjun Ren; Rene O Mejia Sanchez; Blair R Leavitt; Elena Cattaneo; Robert J Ferrante; Michael R Hayden; Robert M Friedlander
Journal:  J Neurochem       Date:  2003-10       Impact factor: 5.372

View more
  42 in total

1.  Regulation of RE1 protein silencing transcription factor (REST) expression by HIP1 protein interactor (HIPPI).

Authors:  Moumita Datta; Nitai P Bhattacharyya
Journal:  J Biol Chem       Date:  2011-08-06       Impact factor: 5.157

Review 2.  Oligonucleotide therapeutic approaches for Huntington disease.

Authors:  Dinah W Y Sah; Neil Aronin
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

3.  Mutant huntingtin disrupts mitochondrial proteostasis by interacting with TIM23.

Authors:  Svitlana Yablonska; Vinitha Ganesan; Lisa M Ferrando; JinHo Kim; Anna Pyzel; Oxana V Baranova; Nicolas K Khattar; Timothy M Larkin; Sergei V Baranov; Ning Chen; Colleen E Strohlein; Donté A Stevens; Xiaomin Wang; Yue-Fang Chang; Mark E Schurdak; Diane L Carlisle; Jonathan S Minden; Robert M Friedlander
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-25       Impact factor: 11.205

4.  Neuronal store-operated calcium entry pathway as a novel therapeutic target for Huntington's disease treatment.

Authors:  Jun Wu; Hsin-Pei Shih; Vladimir Vigont; Lori Hrdlicka; Len Diggins; Carol Singh; Matt Mahoney; Richard Chesworth; Gideon Shapiro; Olga Zimina; Xuesong Chen; Qingqing Wu; Lyubov Glushankova; Michael Ahlijanian; Gerhard Koenig; Galina N Mozhayeva; Elena Kaznacheyeva; Ilya Bezprozvanny
Journal:  Chem Biol       Date:  2011-06-24

5.  Mutant HFE H63D protein is associated with prolonged endoplasmic reticulum stress and increased neuronal vulnerability.

Authors:  Yiting Liu; Sang Y Lee; Elizabeth Neely; Wint Nandar; Mthabisi Moyo; Zachary Simmons; James R Connor
Journal:  J Biol Chem       Date:  2011-02-24       Impact factor: 5.157

6.  Mitochondria modulate programmed neuritic retraction.

Authors:  Sergei V Baranov; Oxana V Baranova; Svitlana Yablonska; Yalikun Suofu; Alberto L Vazquez; Takashi D Y Kozai; X Tracy Cui; Lisa M Ferrando; Timothy M Larkin; Yulia Y Tyurina; Valerian E Kagan; Diane L Carlisle; Bruce S Kristal; Robert M Friedlander
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-24       Impact factor: 11.205

7.  Mutant huntingtin alters cell fate in response to microtubule depolymerization via the GEF-H1-RhoA-ERK pathway.

Authors:  Hemant Varma; Ai Yamamoto; Melissa R Sarantos; Robert E Hughes; Brent R Stockwell
Journal:  J Biol Chem       Date:  2010-09-21       Impact factor: 5.157

Review 8.  The Emerging Roles of Ferroptosis in Huntington's Disease.

Authors:  Yajing Mi; Xingchun Gao; Hao Xu; Yuanyuan Cui; Yuelin Zhang; Xingchun Gou
Journal:  Neuromolecular Med       Date:  2019-01-02       Impact factor: 3.843

Review 9.  Therapeutic approaches to preventing cell death in Huntington disease.

Authors:  Anna Kaplan; Brent R Stockwell
Journal:  Prog Neurobiol       Date:  2012-08-28       Impact factor: 11.685

10.  Allele-specific silencing of mutant Huntington's disease gene.

Authors:  Yu Zhang; Joshua Engelman; Robert M Friedlander
Journal:  J Neurochem       Date:  2009-01       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.